PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-6.23%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-7.26%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-9.56%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-11.12%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-12.95%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-12.96%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-13.15%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.11%
Slight or no buybacks while ON is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
No Data
No Data available this quarter, please select a different quarter.
0.07%
Dividend growth of 0.07% while ON is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-43.19%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-83.44%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
85.25%
10Y revenue/share CAGR under 50% of ON's 208.56%. Michael Burry would suspect a lasting competitive disadvantage.
25.26%
5Y revenue/share CAGR at 50-75% of ON's 40.28%. Martin Whitman would worry about a lagging mid-term growth trajectory.
35.02%
3Y revenue/share CAGR at 75-90% of ON's 45.79%. Bill Ackman would expect new product strategies to close the gap.
293.27%
10Y OCF/share CAGR at 50-75% of ON's 399.49%. Martin Whitman might fear a structural deficiency in operational efficiency.
13.06%
Below 50% of ON's 78.02%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
39.92%
3Y OCF/share CAGR under 50% of ON's 134.18%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
475.86%
Below 50% of ON's 2026.17%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
35.51%
Below 50% of ON's 226.14%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
49.34%
Below 50% of ON's 3235.22%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
69.87%
Below 50% of ON's 385.02%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
55.24%
Below 50% of ON's 117.13%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
102.31%
3Y equity/share CAGR 1.25-1.5x ON's 90.67%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
491.84%
Dividend/share CAGR of 491.84% while ON is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
99.55%
Dividend/share CAGR of 99.55% while ON is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
37.31%
3Y dividend/share CAGR of 37.31% while ON is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-0.95%
Firm’s AR is declining while ON shows 4.58%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
19.26%
Inventory growth well above ON's 12.25%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
7.40%
Asset growth above 1.5x ON's 2.47%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
4.45%
Similar to ON's 4.26%. Walter Schloss finds parallel capital usage or profit distribution strategies.
11.53%
Debt growth far above ON's 8.33%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
4.84%
R&D growth drastically higher vs. ON's 1.47%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
10.49%
We expand SG&A while ON cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.